Linda S. Grais - 15 May 2023 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Linda S. Grais
Issuer symbol
CRVS
Transactions as of
15 May 2023
Net transactions value
+$24,500
Form type
4
Filing time
16 May 2023, 16:54:08 UTC
Previous filing
19 Dec 2022
Next filing
20 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $24,500 +10,000 $2.45 10,000 15 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.